{
  "slug": "delfi-diagnostics",
  "name": "Delfi Diagnostics",
  "description": "Delfi Diagnostics is a biotechnology company developing high-performance, low-cost liquid biopsy tests for the early detection of cancer. The company utilizes a proprietary platform called fragmentomics, which applies machine learning to analyze patterns of DNA fragments in the bloodstream. By focusing on the structural biology of the genome rather than specific mutations, Delfi aims to make cancer screening more accessible and scalable globally.",
  "url": "https://optimly.ai/brand/delfi-diagnostics",
  "logoUrl": "",
  "baiScore": 72,
  "archetype": "Challenger",
  "category": "Biotechnology",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [
    {
      "slug": "guardant-health",
      "name": "Guardant Health"
    }
  ],
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-04-10T08:51:33.819+00:00",
  "verifiedVitals": {
    "website": "https://delfidiagnostics.com/",
    "founded": "2019",
    "headquarters": "Baltimore, Maryland, USA",
    "pricing_model": "Enterprise/Insurance-based clinical testing; Research collaborations.",
    "core_products": "Delfi-LUNG (FirstGen) test, fragmentomics-based liquid biopsy platform.",
    "key_differentiator": "Unlike competitors focusing on deep sequencing of mutations, Delfi uses fragmentomics and AI to deliver high-accuracy cancer detection at a significantly lower cost and higher scalability.",
    "target_markets": "Healthcare providers, oncology centers, health systems, and pharmaceutical researchers.",
    "employee_count": "101-250",
    "funding_stage": "Series B",
    "subcategory": "Molecular Diagnostics / Oncology"
  },
  "intentTags": {
    "problemIntents": [
      "Standard Standard of Care Screening: Physicians rely on standard screening methods like colonoscopies or low-dose CT scans (LDCT) which are invasive or have lower compliance.",
      "Wait-and-See Approach: Monitoring symptoms or waiting for clinical presentations, which often results in late-stage diagnosis.",
      "Tissue Biopsy: Traditional tissue biopsies which require invasive surgical procedures to sample a tumor."
    ],
    "solutionIntents": [
      "What is fragmentomics in cancer detection?",
      "liquid biopsy for lung cancer screening",
      "Johns Hopkins cancer detection spinoffs",
      "cheapest multi-cancer early detection test",
      "FDA approved liquid biopsy for early detection"
    ],
    "evaluationIntents": []
  },
  "timestamp": 1777585526123
}